105 related articles for article (PubMed ID: 9602767)
1. Decreased levels of IGF binding protein-3 in serum from children with Perthes' disease.
Matsumoto T; Enomoto H; Takahashi K; Motokawa S
Acta Orthop Scand; 1998 Apr; 69(2):125-8. PubMed ID: 9602767
[TBL] [Abstract][Full Text] [Related]
2. Skeletal immaturity, IGF-I and IGFBP-3 serum concentrations in Legg-Calvé-Perthes disease (skeletal immaturity, IGF-I and IGFBP-3 in LCPD).
Grasemann H; Nicolai RD; Hauffa BP; Reinhardt W; Nicolai H; Hövel M
Klin Padiatr; 1996; 208(6):339-43. PubMed ID: 8962421
[TBL] [Abstract][Full Text] [Related]
3. Normal plasma levels of IGF binding protein in Perthes' disease. Follow-up of previous report.
Neidel J; Schönau E; Zander D; Rütt J; Hackenbroch MH
Acta Orthop Scand; 1993 Oct; 64(5):540-2. PubMed ID: 7694440
[TBL] [Abstract][Full Text] [Related]
4. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
5. Low plasma levels of insulin-like growth factor I in Perthes' disease. A controlled study of 59 consecutive children.
Neidel J; Zander D; Hackenbroch MH
Acta Orthop Scand; 1992 Aug; 63(4):393-8. PubMed ID: 1529687
[TBL] [Abstract][Full Text] [Related]
6. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
[TBL] [Abstract][Full Text] [Related]
7. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
8. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
9. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.
Flyvbjerg A; Mogensen O; Mogensen B; Nielsen OS
J Clin Endocrinol Metab; 1997 Jul; 82(7):2308-13. PubMed ID: 9215312
[TBL] [Abstract][Full Text] [Related]
11. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver.
Ross RJ; Chew SL; D'Souza Li L; Yateman M; Rodriguez-Arnao J; Gimson A; Holly J; Camacho-Hubner C
J Endocrinol; 1996 May; 149(2):209-16. PubMed ID: 8708531
[TBL] [Abstract][Full Text] [Related]
12. Nutritional modulation of canine insulin-like growth factors and their binding proteins.
Maxwell A; Butterwick R; Yateman M; Batt RM; Cotterill A; Camacho-Hübner C
J Endocrinol; 1998 Jul; 158(1):77-85. PubMed ID: 9713329
[TBL] [Abstract][Full Text] [Related]
13. Fasting affects serum insulin-like growth factors (IGFs) and IGF-binding proteins differently in patients with noninsulin-dependent diabetes mellitus versus healthy nonobese and obese subjects.
Bang P; Brismar K; Rosenfeld RG; Hall K
J Clin Endocrinol Metab; 1994 Apr; 78(4):960-7. PubMed ID: 7512573
[TBL] [Abstract][Full Text] [Related]
14. Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
Lee DY; Kim SJ; Lee YC
J Korean Med Sci; 1999 Aug; 14(4):401-4. PubMed ID: 10485619
[TBL] [Abstract][Full Text] [Related]
15. Circulating insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and tissue mRNA levels of IGFBP-2 and IGFBP-4 in the ovine fetus.
Carr JM; Owens JA; Grant PA; Walton PE; Owens PC; Wallace JC
J Endocrinol; 1995 Jun; 145(3):545-57. PubMed ID: 7543554
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.
Cohen P; Peehl DM; Stamey TA; Wilson KF; Clemmons DR; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Apr; 76(4):1031-5. PubMed ID: 7682560
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation.
Tillmann V; Shalet SM; Price DA; Wales JK; Pennells L; Soden J; Gill MS; Whatmore AJ; Clayton PE
Horm Res; 1998; 50(2):71-7. PubMed ID: 9701699
[TBL] [Abstract][Full Text] [Related]
18. Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
Lee DY; Yang DH; Kang CW; Kim SJ; Joo CU; Cho SC; Kim JS
J Korean Med Sci; 1997 Feb; 12(1):32-9. PubMed ID: 9142657
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid.
Matsumoto T; Gargosky SE; Iwasaki K; Rosenfeld RG
J Clin Endocrinol Metab; 1996 Jan; 81(1):150-5. PubMed ID: 8550744
[TBL] [Abstract][Full Text] [Related]
20. Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate.
Moriwake T; Abribat T; Brazeau P; Ecarot B
J Bone Miner Res; 1995 Nov; 10(11):1698-704. PubMed ID: 8592946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
